Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial.

Campbell NL, Dexter P, Perkins AJ, Gao S, Li L, Skaar TC, Frame A, Hendrie HC, Callahan CM, Boustani MA.

Trials. 2013 May 4;14:125. doi: 10.1186/1745-6215-14-125.

2.

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial.

Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.

J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.

PMID:
28295141
3.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

4.

Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.

Mucha L, Shaohung S, Cuffel B, McRae T, Mark TL, Del Valle M.

J Manag Care Pharm. 2008 Jun;14(5):451-61.

5.

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.

Thompson S, Lanctôt KL, Herrmann N.

Expert Opin Drug Saf. 2004 Sep;3(5):425-40. Review.

PMID:
15335298
7.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
8.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
9.

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.

Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group.

Curr Alzheimer Res. 2008 Feb;5(1):83-9.

PMID:
18288936
10.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.

Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8.

PMID:
11921156
11.

Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Kröger E, van Marum R, Souverein P, Egberts T.

Drugs Aging. 2010 Aug 1;27(8):663-75. doi: 10.2165/11538230-000000000-00000.

PMID:
20658794
12.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
13.
14.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
15.

Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.

Auriacombe S, Pere JJ, Loria-Kanza Y, Vellas B.

Curr Med Res Opin. 2002;18(3):129-38.

PMID:
12094822
16.

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.

Campbell NL, Skaar TC, Perkins AJ, Gao S, Li L, Khan BA, Boustani MA.

Clin Interv Aging. 2015 Jan 14;10:269-75. doi: 10.2147/CIA.S65980. eCollection 2015.

17.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747. Review.

PMID:
16437436
18.

Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study.

Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B.

CNS Drugs. 2010 May;24(5):431-42. doi: 10.2165/11318010-000000000-00000.

PMID:
20369907
19.

Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.

Froelich L, Gertz HJ, Heun R, Heuser I, Jendroska K, Kornhuber J, Kurz A, Mueller-Thomsen T, Ries F, Waechtler C, Metz M, Goebel C.

Dement Geriatr Cogn Disord. 2004;18(1):37-43. Epub 2004 Apr 6.

PMID:
15084792
20.

Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial.

Callahan CM, Boustani MA, Schmid AA, Austrom MG, Miller DK, Gao S, Morris CS, Vogel M, Hendrie HC.

Trials. 2012 Jun 27;13:92. doi: 10.1186/1745-6215-13-92.

Supplemental Content

Support Center